文献速递妇产影像泌尿生殖US

交叉征对剖宫产瘢痕妊娠超声引导下负压吸引术结局的预测价值

Predictive value of crossover sign for outcome of ultrasound-guided vacuum aspiration in women with Cesarean scar pregnancy.
PubMed 文献 · Ultrasound Obstet Gynecol · 2024-02-26

回顾性队列研究纳入181例剖宫产瘢痕妊娠(CSP)患者,按交叉征(COS)分为COS-1组90例(49.7%)和COS-2组91例(50.3%),分析COS类型与超声引导下负压吸引术结局的关系。COS-1组治疗失败率25.6%,高于COS-2组的8.8%(P=0.003),且妊娠组织残留、二次治疗及出血≥200 mL发生率均更高。COS-1和大孕囊(直径30.1-50.0 mm或>50.0 mm)为治疗失败的独立危险因素。

要点

  • COS-1型CSP负压吸引术治疗失败率25.6%,高于COS-2型的8.8%(P=0.003)。
  • COS-1型妊娠组织残留18.9% vs COS-2型6.6%(P=0.013),二次治疗20.0% vs 6.6%(P=0.002),出血≥200 mL 13.3% vs 4.4%(P=0.034)。
  • COS-1型治疗失败OR 4.57(95%CI 1.66-12.56,P=0.003);孕囊直径30.1-50.0 mm OR 4.34(95%CI 1.35-13.94,P=0.014),>50.0 mm OR 10.50(95%CI 2.54-43.46,P=0.001)。

核心结论

  • 超声评估孕囊与子宫内膜线的关系(COS分类)可能有助于预测CSP患者负压吸引术的治疗结局;作者认为COS-1患者尤其是孕囊直径>30.0 mm者,可能不宜行负压吸引术。

研究设计与样本

  • 回顾性队列研究,纳入181例接受超声引导下负压吸引术的CSP患者,按孕囊、剖宫产瘢痕与子宫前壁的关系分为COS-1型(90例,49.7%)和COS-2型(91例,50.3%)。

关键影像表现/征象

  • COS分型基于超声显示的孕囊、剖宫产瘢痕与子宫前壁的关系,以及孕囊与子宫内膜线的关系。
  • COS-1型患者治疗失败、妊娠组织残留、二次治疗及出血≥200 mL的发生率均高于COS-2型。

诊断标准与关键数值

  • COS-1型治疗失败率25.6% vs COS-2型8.8%(P=0.003)。
  • COS-1型妊娠组织残留率18.9% vs COS-2型6.6%(P=0.013)。
  • COS-1型二次治疗率20.0% vs COS-2型6.6%(P=0.002)。
  • COS-1型出血≥200 mL发生率13.3% vs COS-2型4.4%(P=0.034)。
  • COS-1型治疗失败OR 4.57(95%CI 1.66-12.56,P=0.003);孕囊直径30.1-50.0 mm OR 4.34(95%CI 1.35-13.94,P=0.014);孕囊直径>50.0 mm OR 10.50(95%CI 2.54-43.46,P=0.001)。

临床应用与阅片要点

  • 超声评估CSP孕囊与子宫内膜线的关系并进行COS分型,可能有助于预测负压吸引术的治疗结局。
  • 作者认为COS-1型患者,尤其是孕囊直径>30.0 mm者,可能不宜行负压吸引术。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: To examine the value of the crossover sign (COS) in predicting treatment outcome in women with a Cesarean scar pregnancy (CSP) who were treated with ultrasound-guided vacuum aspiration.

METHODS: This was a retrospective cohort study of women with CSP who underwent ultrasound-guided vacuum aspiration. Based on the relationship between the gestational sac, Cesarean scar and anterior wall of the uterus, CSPs were classified by COS type. Analysis was conducted to investigate the association between COS type (COS-1, COS-2) and treatment outcome. The incidence of treatment failure, retained pregnancy tissue, secondary therapy and bleeding ≥ 200 mL were analyzed.

RESULTS: In total, 181 eligible patients with CSP, including 90 (49.7%) women with COS-1 and 91 (50.3%) women with COS-2, were analyzed. COS-1 patients had a higher incidence of treatment failure compared with COS-2 patients (25.6% vs 8.8%; P = 0.003), as well as higher rates of retained pregnancy tissue (18.9% vs 6.6%; P = 0.013), secondary therapy (20.0% vs 6.6%; P = 0.002) and bleeding of ≥ 200 mL (13.3% vs 4.4%; P = 0.034). COS-1 and a large gestational sac (30.1-50.0 mm or >50.0 mm in diameter) were associated independently with increased risk of treatment failure (odds ratio, 4.57 (95% CI, 1.66-12.56); P = 0.003, 4.34 (95% CI, 1.35-13.94); P = 0.014 and 10.50 (95% CI, 2.54-43.46); P = 0.001, respectively).

CONCLUSIONS: Ultrasound evaluation of the relationship between the gestational sac and the endometrial line (COS classification) in women with CSP may help to predict treatment outcome among those undergoing vacuum aspiration. Among COS-1 patients, especially those with a gestational sac diameter of >30.0 mm, vacuum aspiration may be discouraged. © 2023 International Society of Ultrasound in Obstetrics and Gynecology.

来源:Ultrasound Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Shen M, Li L, Zhu L, et al. Predictive value of crossover sign for outcome of ultrasound-guided vacuum aspiration in women with Cesarean scar pregnancy. Ultrasound Obstet Gynecol. 2024. PMID: 37610656. doi:10.1002/uog.27459

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。